Cohance Lifesciences Limited
COHANCE
Clasificación en acciones
#6496
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Precio por acción
$4.80
Capitalización bursátil
$1.84B
Cambio (1 día)
-5.65%
Cambio (1 año)
-59.50%
País
IN
Comercio Cohance Lifesciences Limited (COHANCE)
Categoría
Healthcare
Historial del precio de la acción de Cohance Lifesciences Limited (COHANCE)
Precio más alto de cierre: $12.03 el 2025-06-01
Precio más bajo de cierre: $1.65 el 2020-03-01
Precio más bajo de cierre: $1.65 el 2020-03-01
Historial del precio de la acción de Cohance Lifesciences Limited desde 2020 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2025 | -17.24% |
| 2024 | 75.72% |
| 2023 | 43.40% |
| 2022 | -12.41% |
| 2021 | 15.53% |
| 2020 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
